drugset / Trial / NCT05089344
Growth Hormone Pretreatment in Poseidon Type IV Undergoing ICSI Using Minimal Induction Protocol: A Randomized Controlled Trial
RandomizedSingle-groupOpen-labelTreatment
Summary
This study is done aiming to Assess Efficiency of Growth hormone as an adjuvant in pretreatment of Poseidon type IV group " poor responders "undergoing ICSI using minimal induction protocol
Timeline
- Start
- 2021-10-09
- Primary completion
- 2022-10-30
- Completion
- 2022-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Somatropin | Protein / enzyme biologic | 8 iu | — |
| Background | Clomiphene Citrate | Other / unclassified | 100 mg | — |
| Background | recombinant FSH | Protein / enzyme biologic | 150 iu | — |